PATHOLOGIC STAGE IV CUTANEOUS MELANOMA AJCC V8
Clinical trials for PATHOLOGIC STAGE IV CUTANEOUS MELANOMA AJCC V8 explained in plain language.
Never miss a new study
Get alerted when new PATHOLOGIC STAGE IV CUTANEOUS MELANOMA AJCC V8 trials appear
Sign up with your email to follow new studies for PATHOLOGIC STAGE IV CUTANEOUS MELANOMA AJCC V8, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Scientists test re-engineered immune cells to fight advanced cancers
Disease control Recruiting nowThis early-stage study is testing a new type of cell therapy for people with advanced solid tumors, including melanoma, that have spread and are not responding to standard treatments. Doctors take a patient's own immune cells, modify them in a lab to better recognize and attack c…
Matched conditions: PATHOLOGIC STAGE IV CUTANEOUS MELANOMA AJCC V8
Phase: PHASE1 • Sponsor: Anusha Kalbasi • Aim: Disease control
Last updated Apr 03, 2026 18:10 UTC
-
New pill targets advanced cancers in early safety trial
Disease control Recruiting nowThis is an early-stage study to find safe doses of a new oral drug called IACS-6274. It will be tested alone and in combination with other cancer drugs in adults with advanced solid tumors that have stopped responding to standard treatments. The main goals are to check for side e…
Matched conditions: PATHOLOGIC STAGE IV CUTANEOUS MELANOMA AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC
-
Donor immune cells target deadly brain tumors in new cancer trial
Disease control Recruiting nowThis early-stage trial is testing a new combination treatment for melanoma that has spread to the brain. Researchers are giving patients immune cells from a universal donor (called NK cells) along with a standard chemotherapy drug (temozolomide). The study aims to find the safest…
Matched conditions: PATHOLOGIC STAGE IV CUTANEOUS MELANOMA AJCC V8
Phase: PHASE1, PHASE2 • Sponsor: Kari Kendra • Aim: Disease control
Last updated Mar 30, 2026 14:32 UTC
-
New pill combo targets deadly melanoma in the brain
Disease control Recruiting nowThis study is testing if two oral drugs, binimetinib and encorafenib, can help control melanoma that has spread to the brain or spinal fluid. It is for adults whose melanoma has a specific genetic change called BRAF V600 and has progressed after prior treatment. The main goals ar…
Matched conditions: PATHOLOGIC STAGE IV CUTANEOUS MELANOMA AJCC V8
Phase: PHASE2 • Sponsor: M.D. Anderson Cancer Center • Aim: Disease control
Last updated Mar 30, 2026 14:28 UTC
-
Brain battle: two drug cocktails face off against deadly melanoma spread
Disease control Recruiting nowThis trial is testing which of two drug combinations works better for people with advanced melanoma that has spread to the brain. One group gets three drugs (encorafenib, binimetinib, nivolumab), while the other gets two drugs (ipilimumab, nivolumab). The main goal is to see whic…
Matched conditions: PATHOLOGIC STAGE IV CUTANEOUS MELANOMA AJCC V8
Phase: PHASE2 • Sponsor: SWOG Cancer Research Network • Aim: Disease control
Last updated Mar 25, 2026 14:09 UTC
-
Could poop transplants ease cancer drug side effects?
Knowledge-focused Recruiting nowThis study aims to understand why some cancer patients develop severe diarrhea and colon inflammation (colitis) while taking powerful immunotherapy drugs called immune checkpoint inhibitors. Researchers will collect stool, blood, and tissue samples from 800 patients with melanoma…
Matched conditions: PATHOLOGIC STAGE IV CUTANEOUS MELANOMA AJCC V8
Phase: PHASE1 • Sponsor: M.D. Anderson Cancer Center • Aim: Knowledge-focused
Last updated Mar 05, 2026 14:00 UTC